Cyclacel Pharmaceuticals (CYCC)
(Delayed Data from NSDQ)
$1.32 USD
-0.13 (-8.97%)
Updated Aug 15, 2024 03:59 PM ET
After-Market: $1.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.62 |
EPS Last Quarter | -0.72 |
Last EPS Surprise | 13.25% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.93 |
Next Year | -4.33 |
EPS (TTM) | -16.57 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03M | 0.03M | 0.12M | 0.10M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.03M | 0.03M | 0.12M | 0.10M |
Low Estimate | 0.03M | 0.03M | 0.12M | 0.10M |
Year ago Sales | 0.02M | 0.03M | 0.42M | 0.12M |
Year over Year Growth Est. | 50.00% | 0.00% | -71.43% | -16.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.62 | -0.42 | -4.93 | -4.33 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.83 | -0.62 | -2.71 | -1.69 |
High Estimate | -0.62 | -0.42 | -2.71 | -1.69 |
Low Estimate | -0.62 | -0.42 | -7.15 | -6.96 |
Year ago EPS | -7.35 | -6.23 | -26.75 | -4.93 |
Year over Year Growth Est. | 91.56% | 93.26% | 81.57% | 12.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.62 | -0.42 | -4.93 | -4.33 |
7 Days Ago | -0.62 | -0.42 | -4.93 | -4.33 |
30 Days Ago | -0.62 | -0.42 | -4.93 | -4.33 |
60 Days Ago | -0.62 | -0.42 | -4.93 | -4.33 |
90 Days Ago | -1.02 | -1.03 | -33.00 | -5.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.42 | -4.93 | -4.33 |
Zacks Consensus Estimate | -0.62 | -0.42 | -4.93 | -4.33 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.72 | -2.27 | -6.23 | -7.35 | NA |
Estimate | -0.83 | -4.93 | -6.35 | -5.70 | NA |
Difference | 0.11 | 2.66 | 0.12 | -1.65 | 0.31 |
Surprise | 13.25% | 53.96% | 1.89% | -28.95% | 10.04% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more